Singapore markets open in 2 hours 12 minutes

Repare Therapeutics Inc. (RPTX)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
8.86-0.20 (-2.21%)
At close: 04:00PM EDT
8.86 0.00 (0.00%)
After hours: 04:00PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 379.56M
Enterprise value 74.91M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/sales (ttm)45.12
Price/book (mrq)1.47
Enterprise value/revenue 9.55
Enterprise value/EBITDA -0.62

Trading information

Stock price history

Beta (5Y monthly) N/A
52-week change 3-73.45%
S&P500 52-week change 3-0.65%
52-week high 335.75
52-week low 38.33
50-day moving average 312.12
200-day moving average 320.69

Share statistics

Avg vol (3-month) 3165.09k
Avg vol (10-day) 3220.24k
Shares outstanding 541.89M
Implied shares outstanding 6N/A
Float 819.03M
% held by insiders 111.35%
% held by institutions 191.67%
Shares short (28 Apr 2022) 42.59M
Short ratio (28 Apr 2022) 413.88
Short % of float (28 Apr 2022) 49.87%
Short % of shares outstanding (28 Apr 2022) 46.17%
Shares short (prior month 30 Mar 2022) 42.96M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)30 Dec 2021


Profit margin 0.00%
Operating margin (ttm)-1,429.74%

Management effectiveness

Return on assets (ttm)-18.71%
Return on equity (ttm)-37.17%

Income statement

Revenue (ttm)7.6M
Revenue per share (ttm)0.20
Quarterly revenue growth (yoy)4,994.10%
Gross profit (ttm)-80.25M
EBITDA -107.19M
Net income avi to common (ttm)-106.91M
Diluted EPS (ttm)-2.83
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)341.87M
Total cash per share (mrq)8.16
Total debt (mrq)7.31M
Total debt/equity (mrq)2.54
Current ratio (mrq)10.02
Book value per share (mrq)6.89

Cash flow statement

Operating cash flow (ttm)-85.8M
Levered free cash flow (ttm)-28.96M